Anticipated Shortage

CARMUSTINE FOR INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of CARMUSTINE FOR INJECTION USP in Canada?

A shortage of CARMUSTINE FOR INJECTION USP 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 4, 2026), but it has not started yet.

Why is CARMUSTINE FOR INJECTION USP not available?

The reason the manufacturer reported: Demand increase for the drug.

When will CARMUSTINE FOR INJECTION USP be available again?

The estimated resolution date (September 21, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file2 products

Affected strength100MG

Last updated2026-09-04

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

BICNU

MARCAN PHARMACEUTICALS INC

100MG · DIN 00297763

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

GLIADEL WAFER

EISAI LIMITED

7.7MG · DIN 02238985

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2026-09-21

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02531879

Strength

100MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

CARMUSTINE

Tier

Unrated

Last Updated

2026-09-04

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890